LOL! With 28 years of seasoned experience, what did the EUA announcement PR uncover?
CytoDyn Requests Covid-19 Emergency Use Approval For Leronlimab support@smarteranalyst.com (Ben Mahaney)
August 17, 2020·3 min read
Late-stage biotech CytoDyn Inc (CYDY) has announced that it has provided its Top-line Report from its recently completed Phase 2 trial of leronlimab for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval. https://finance.yahoo.com/news/cytodyn-requests-covid-19-emergency-125739300.html
Gotta believe Dr Lalezare on this. If you know he is lying about this --very disappointed in Dr Lalezare
DrJay @DrJay62817871
Aug 1, 2021 SEC investigating CYDY for public claims about leronlimab for Covid. I made such statements while interim CMO at CYDY and stand by them. I believe leronlimab helps at least some if not many patients critically ill with Covid-19.